224 related articles for article (PubMed ID: 19751777)
1. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance.
Khdair A; Chen D; Patil Y; Ma L; Dou QP; Shekhar MP; Panyam J
J Control Release; 2010 Jan; 141(2):137-44. PubMed ID: 19751777
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
Khdair A; Handa H; Mao G; Panyam J
Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
[TBL] [Abstract][Full Text] [Related]
3. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
Chavanpatil MD; Khdair A; Panyam J
Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of drug loaded glycyrrhetinic acid modified alginate nanoparticles on mice bearing orthotopic liver tumor.
Zhang C; Wu Y; Liu T; Zhao Y; Wang X; Wang W; Yuan Z
J Control Release; 2011 Nov; 152 Suppl 1():e111-3. PubMed ID: 22195787
[No Abstract] [Full Text] [Related]
5. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
6. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
[TBL] [Abstract][Full Text] [Related]
7. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy.
Khdair A; Gerard B; Handa H; Mao G; Shekhar MP; Panyam J
Mol Pharm; 2008; 5(5):795-807. PubMed ID: 18646775
[TBL] [Abstract][Full Text] [Related]
8. Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles.
Usacheva M; Swaminathan SK; Kirtane AR; Panyam J
Mol Pharm; 2014 Sep; 11(9):3186-95. PubMed ID: 25061685
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
[TBL] [Abstract][Full Text] [Related]
10. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Khdair A; Gerard B; Bachmeier C; Miller DW; Shekhar MP; Panyam J
Mol Pharm; 2007; 4(5):730-8. PubMed ID: 17705442
[TBL] [Abstract][Full Text] [Related]
11. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
12. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
13. Leveraging a polycationic polymer to direct tunable loading of an anticancer agent and photosensitizer with opposite charges for chemo-photodynamic therapy.
Zhao M; Wan S; Peng X; Zhang B; Pan Q; Li S; He B; Pu Y
J Mater Chem B; 2020 Feb; 8(6):1235-1244. PubMed ID: 31957757
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy.
Brulé S; Levy M; Wilhelm C; Letourneur D; Gazeau F; Ménager C; Le Visage C
Adv Mater; 2011 Feb; 23(6):787-90. PubMed ID: 21287643
[No Abstract] [Full Text] [Related]
16. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
Baghbani F; Moztarzadeh F
Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
[TBL] [Abstract][Full Text] [Related]
17. Injectable hybrid laponite/alginate hydrogels for sustained release of methylene blue.
Li Y; Santos JL; Maciel D; Tomás H; Rodrigues J
J Control Release; 2011 Nov; 152 Suppl 1():e55-7. PubMed ID: 22195924
[No Abstract] [Full Text] [Related]
18. Ultra-thin metal-organic framework nanosheets for chemo-photodynamic synergistic therapy.
Zeng R; He T; Lu L; Li K; Luo Z; Cai K
J Mater Chem B; 2021 May; 9(20):4143-4153. PubMed ID: 33973611
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
20. Multimodal doxorubicin loaded magnetic nanoparticles for VEGF targeted theranostics of breast cancer.
Semkina AS; Abakumov MA; Skorikov AS; Abakumova TO; Melnikov PA; Grinenko NF; Cherepanov SA; Vishnevskiy DA; Naumenko VA; Ionova KP; Majouga AG; Chekhonin VP
Nanomedicine; 2018 Jul; 14(5):1733-1742. PubMed ID: 29730399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
